NewsRoom Articles - Page 2 of 239

TuesdayApr 09, 2024 2:30 pm

New Scientific Review Highlights Potential of CBD in Treating Cancer, COVID Pain

A recently conducted scientific review has called attention to CBD’s potential in managing and treating symptoms of conditions such as diabetes, pain, epilepsy, schizophrenia, COVID-19 and cancer, among others. The review tries to summarize the impact of marijuana on human health, noting that the plant and its compounds demonstrate anti-inflammatory, neuroprotective, antibacterial, antithrombotic, antiepileptic and analgesic properties. Through funding from the National Product Institute of Science and Technology, the study also examined recent research advancements on CBD, focusing on possible medical applications. The review was carried out by an eight-person team from South Korea, representing the National Product Institute of…

ThursdayApr 04, 2024 10:00 am

NY Hemp Firms Refile Lawsuit Against Law Banning Intoxicants from Hemp

A coalition of companies in New York has refiled a suit against the Office of Cannabis Management and the state’s Cannabis Control Board. The state-licensed operators claim that New York’s new rules on hemp-derived cannabinoid products have cost them losses adding up to millions of dollars. The companies hope to be awarded an injunction that would allow them to continue selling hemp products. This comes after a judge dismissed a similar case filed prior to this one on technical grounds. In their statement, the plaintiffs note that the raids were part of a larger crackdown on the illegal marijuana trade…

TuesdayApr 02, 2024 10:00 am

USDA Greenlights Modified Hemp Variant Free from CBD, THC

The U.S. Department of Agriculture (“USDA”) recently gave the green light to genetically engineered hemp that doesn’t produce cannabidiol (“CBD”) or tetrahydrocannabinol (“THC”). This is the second genetically engineered variety of hemp to receive approval from the USDA. A low CBD-and THC strain by Growing Together Research was approved by the agency last year. Hemp, under the 2018 Farm Bill, is defined as the cannabis sativa plant and any part with nothing more than 0.3% delta-9 THC concentration on dry weight basis. Anything above this limit is categorized as marijuana. While there are different varieties of hemp that are low…

ThursdayMar 28, 2024 2:30 pm

Nebraska Lawmakers Pass Bill Imposing 100% Tax on CBD, Hemp Products

A legislative committee in Nebraska has approved a measure that would impose a 100% tax on CBD and hemp products in the state. The committee approved the bill in a 7 to 0 vote. It is expected that the state’s unicameral legislature will take up the proposed legislation later this week. According to the bill’s sponsor, Senator Lou Ann Linehan, this tax hike is focused on bringing in additional funds to help offset property tax bills. The bill also includes reforms such as the elimination of sales tax exemptions on candy, soda, pet services, lottery tickets and ad revenue. This…

ThursdayMar 28, 2024 9:00 am

Astrotech Corp. (NASDAQ: ASTC) and AgLAB Inc. Use Mass Spectrometer Technology to Significantly Enhance Hemp and Cannabis Production Yield and Profit

The cannabinoid market value in 2023 was $22.23 billion and is expected to grow at a CAGR of 15.3%, resulting in an estimated market value of $60.36 billion The global mass spectrometry market will reach $6.77 billion in 2024 and is expected to grow at a CAGR of 6.25%, reaching $9.17 billion by 2029. Astrotech and subsidiary AgLAB Inc. are using mass spectrometry to boost the profitable yield of hemp and cannabis production The United States has seen a rising awareness of the health and therapeutic benefits of cannabinoids, prompting an expected market increase of 15.3%, from $22.23 billion in…

TuesdayMar 26, 2024 10:00 am

21 State AGs Urge Congress to Act on Hemp-Derived Intoxicants

Attorney generals from various states across the country as well as Washington, D.C., are urging leaders in Congress to act on hemp-derived intoxicants. In a letter penned to legislators in the Senate and House agriculture committees, these top state law-enforcement officials asked that legislators revise hemp’s definition in the 2018 Farm Bill and allow states to implement their own initiatives to regulate the crop and its products. The bill defines hemp as cannabis with a delta-9 THC concentration not exceeding 0.3% on a dry weight basis but exempts other derivatives and extracts. This loophole has allowed intoxicants from hemp to…

MondayMar 25, 2024 12:45 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires Contract Research Organization to Perform Important GLP-1 Human Pilot Study

Lexaria, a global innovator in drug delivery platforms, recently hired a Contract Research Organization to perform their second GLP-1 human pilot study which will test a dissolvable DehydraTECH-GLP-1 oral dose formulation The announcement follows Lexaria’s WEIGHT-A24-1 animal study announcement examining diabetes and weight loss effects of DehydraTECH-processed GLP-1 drugs and cannabidiol alone and in combination The move aligns with the company’s resolve to focus on their ability to enhance the delivery of GLP-1 diabetes and obesity drugs At the beginning of the year, Lexaria Bioscience (NASDAQ: LEXX), a global innovator for enhanced drug delivery platforms, announced its intention to double down…

ThursdayMar 21, 2024 2:00 pm

Arizona Attorney General Says Hemp-Based THC Products Are Illegal

Attorney General Kris Mayes of Arizona recently gave her opinion on the sale of products derived from hemp in the state, focusing on delta-8 tetrahydrocannabinol (“THC”). This compound, which has a similar make up to delta-9 THC, is manufactured from cannabis, which naturally occurs in hemp. Hemp was legalized with the passing of the 2018 Farm Bill, which allowed CBD derived from hemp to be synthesized into THC. Since then, states such as Arizona have seen the proliferation of delta-8 THC products in various retail locations, including convenience stores and gas stations but not in state-licensed dispensaries. These products are…

ThursdayMar 21, 2024 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-CBD Achieves 7% Weight Loss; Sets Stage for 8-week Diabetes and Weight Loss Animal Study

Lexaria, a global innovator in drug delivery platforms, highlighted results from its DIAB-A22-1 animal study, highlighting a 7% reduction in weight and a 19.9% reduction in blood glucose With this success, Lexaria looks to kick off its WEIGHT-A24-1 animal study to examine diabetes and weight loss effects of its patented DehydraTECH(TM)-processed GLP-1 drugs and DehydraTECH-processed CBD The study will comprise 12 arms and involve 72 animals. It will run for a total of 12 weeks This study will build on previous studies that evidenced DehydraTECH’s potential to enable greater penetration of GLP-1 drugs into the brain tissue Lexaria Bioscience (NASDAQ:…

TuesdayMar 19, 2024 3:00 pm

USDA Publishes Roadmap for Hemp Highlighting Research Needs

Hemp was federally legalized under the 2018 Farm Bill, permitting its cultivation and production. Last week, the U.S. agriculture department published a roadmap for hemp that focused on the crop’s research needs. The roadmap is divided into the following areas: best production practices, genetics and breeding, consistency and transparency, and biomanufacturing for end uses. The department explained that these areas were important in strengthening research on the hemp industry and focused on the entire hemp supply chain. The roadmap is the outcome of a National Hemp Industry workshop held in 2022 that was organized by the Global Hemp Innovation Center…